GxPinnacle Logo
Skip to content

What Do Inspectors Check for Vendor Selection and Approval Process in Pharmacovigilance?

Pharmacovigilance systems must apply a structured vendor selection and approval process. Regulators expect defined criteria, documented evaluation, risk-based decisions, and formal approval before engaging vendors.

For: Founders, CEOs & MDs·PV Leads·QA/Compliance·Scientists tasked with documentation

Alignment: Global pharmacovigilance principles (ICH-aligned) and inspection practices

Most useful when: Preparing for inspection, setting up a process, or closing a documentation gap

Key points

  • Pharmacovigilance vendors must be selected through a structured and documented evaluation process.
  • Selection criteria must include capability, compliance, experience, systems, and regulatory alignment.
  • Vendor selection must be supported by due diligence and risk assessment outputs.
  • Final approval must be formally documented and authorised by PV, QA, and QPPV or delegated roles.
  • Vendor selection decisions must be justified and traceable to evaluation criteria.
  • Inspection-ready evidence must demonstrate that vendor selection is controlled, risk-based, and approved before engagement.

What inspectors expect

Each point below should be supported by controlled documents and traceable records.

  • Vendor selection must be based on defined and documented criteria.
  • Selection decisions must be supported by due diligence and risk assessment.
  • Vendor capability and compliance must be verified before approval.
  • Approval must be formally authorised by appropriate roles.
  • Vendor selection must be justified and traceable.

Summary

Inspectors assess whether pharmacovigilance vendors are selected and approved through a structured, risk-based process. They typically review selection criteria, evaluation outputs, approval decisions, and evidence that the chosen vendor was justified and formally authorised before engagement.

Common questions

These are the questions this page is designed to answer directly.

  • How are pharmacovigilance vendors selected?
  • What is the vendor approval process in pharmacovigilance?
  • What do inspectors check for vendor selection?
  • How do you approve a PV vendor?
  • What criteria are used to select pharmacovigilance vendors?
  • Who approves vendors in pharmacovigilance?
  • How do regulators assess vendor approval decisions?
  • What documentation is required for vendor selection?
  • How do you justify vendor selection in inspections?
  • What is the vendor onboarding process in pharmacovigilance?

Evidence objects inspectors expect

Vendor Selection Criteria

  • Defined criteria for evaluating vendor capability
  • Assessment of PV process experience and expertise
  • Evaluation of regulatory compliance and inspection history
  • Assessment of IT systems, validation, and data security
  • Geographic and regulatory coverage requirements

Vendor Shortlisting and Evaluation Records

  • List of potential vendors considered
  • Comparison of vendor capabilities and services
  • Evaluation notes and scoring against criteria
  • Justification for selecting preferred vendor

Due Diligence and Risk Assessment Outputs

  • Completed vendor questionnaires
  • Risk classification and rationale
  • Audit outcomes or audit decision records
  • Identification of strengths, weaknesses, and gaps

Vendor Approval Documentation

  • Formal approval record for selected vendor
  • QA and PV review of selection decision
  • QPPV or delegated sign-off
  • Documented justification for approval

Vendor Onboarding and Readiness Evidence

  • Initial onboarding meeting records
  • System access setup and validation checks
  • Confirmation of process alignment with SOPs
  • Defined communication and escalation pathways

Regulatory Basis (Primary Sources)

  • GVP Module I – MAH responsibility for selection and oversight of third parties
  • GVP Module VI – requirement for compliant handling of safety data through capable systems
  • ICH E2D – need for reliable processes supporting safety data management
  • MHRA GPvP guidance – expectations for vendor selection and qualification
  • FDA pharmacovigilance guidance – responsibility for vendor selection and compliance remains with the MAH

Typical Inspection Questions (What Inspectors Ask)

  • How did you select this vendor?
  • What criteria were used to evaluate vendors?
  • Why was this vendor chosen over others?
  • Who approved the vendor and on what basis?
  • Show me the documentation supporting this decision.

Failure patterns

Vendor selection is based on cost or convenience rather than capability.

No documented evaluation or comparison of vendors.

Selection criteria are undefined or inconsistently applied.

Vendor approval is not formally documented or authorised.

The selected vendor does not meet regulatory or operational requirements.

What good looks like

  • A structured and documented vendor selection process.
  • Clear evaluation criteria applied consistently across candidates.
  • Evidence-based comparison and justification of vendor choice.
  • Formal approval process involving PV, QA, and QPPV roles.
  • Alignment between selected vendor capability and service requirements.

Operationalisation

  • Define vendor selection criteria aligned with PV requirements.
  • Create a shortlist of potential vendors based on service needs.
  • Evaluate vendors using questionnaires, documentation review, and risk assessment.
  • Document comparison and selection rationale.
  • Obtain formal approval from PV, QA, and QPPV or delegated authority.
  • Complete onboarding and confirm vendor readiness before starting activities.

Need regulatory documentation today?

Save time and reduce inspection risk with structured, pre-built process-ready documentation.
Created by industry professionals, adaptable to your organisation.

Related pre-built documentation inside the app

Get AccessLog In

FAQ

How do you choose a pharmacovigilance vendor?

A pharmacovigilance vendor is chosen through a structured process that includes defining selection criteria, shortlisting candidates, performing due diligence and risk assessment, comparing vendor capabilities, and obtaining formal approval based on documented evaluation.

How are pharmacovigilance vendors selected?

Vendors are selected through a structured evaluation process that assesses capability, compliance, experience, systems, and regulatory alignment against defined criteria.

Who approves a pharmacovigilance vendor?

Vendor approval is typically performed by PV Operations, Quality Assurance, and the QPPV or delegated authority based on documented evaluation and risk assessment.

What criteria are used to select a PV vendor?

Criteria typically include PV expertise, regulatory compliance history, system validation, data security, geographic coverage, and operational capability.

Do inspectors review vendor selection decisions?

Yes. Inspectors review how vendors were selected, what criteria were applied, and whether the decision was justified and formally approved.

What happens if vendor selection is not properly documented?

Lack of documentation can result in inspection findings, as regulators expect clear justification for vendor selection decisions.

What is the vendor onboarding process in pharmacovigilance?

Onboarding includes contract execution, SDEA setup, system access configuration, process alignment, and confirmation that the vendor is ready to perform PV activities.

Sources

Primary guidance used to inform this map. This page is a structured interpretation layer; always validate against the original source documents.

European Medicines Agency (EMA)

  • Guideline on good pharmacovigilance practices (GVP) – Module I
    View source
  • Guideline on good pharmacovigilance practices (GVP) – Module VI
    View source

FDA

ICH

MHRA